Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

40 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Reproducibility of normal facial motor nerve conduction studies and their relevance in the electrophysiological assessment of peripheral facial paralysis.
Di Bella P, Logullo F, Lagalla G, Sirolla C, Provinciali L. Di Bella P, et al. Neurophysiol Clin. 1997 Sep;27(4):300-8. doi: 10.1016/S0987-7053(97)85828-5. Neurophysiol Clin. 1997. PMID: 9350062
Relationship between lipoprotein(a) levels, oxidative stress, and blood pressure levels in patients with essential hypertension.
Antonicelli R, Testa R, Bonfigli AR, Sirolla C, Pieri C, Marra M, Marcovina SM. Antonicelli R, et al. Clin Exp Med. 2001 Sep;1(3):145-50. doi: 10.1007/s10238-001-8026-z. Clin Exp Med. 2001. PMID: 11833851
Fibronectin and lipoprotein(a) are inversely related to plasminogen activator inhibitor type-1 levels in Type 2 diabetic patients without complications.
Testa R, Bonfigli AR, Sirolla C, De Grazia G, Compagnucci P, Manfrini S, Fumelli D, Testa I. Testa R, et al. Diabetes Nutr Metab. 2000 Oct;13(5):269-75. Diabetes Nutr Metab. 2000. PMID: 11105969
Interleukin-6-174 G > C polymorphism affects the association between IL-6 plasma levels and insulin resistance in type 2 diabetic patients.
Testa R, Olivieri F, Bonfigli AR, Sirolla C, Boemi M, Marchegiani F, Marra M, Cenerelli S, Antonicelli R, Dolci A, Paolisso G, Franceschi C. Testa R, et al. Diabetes Res Clin Pract. 2006 Mar;71(3):299-305. doi: 10.1016/j.diabres.2005.07.007. Epub 2005 Sep 2. Diabetes Res Clin Pract. 2006. PMID: 16140413
Control subjects, both C+ (CG + CC genotypes) and C- (GG genotype) carriers, showed IL-6 plasma levels significantly related to BMI, fasting insulin and HOMA. ...These findings highlight that IL-6-174 G > C polymorphism affects insulin resistance in type 2 …
Control subjects, both C+ (CG + CC genotypes) and C- (GG genotype) carriers, showed IL-6 plasma levels significantly related t …
Lipoprotein(a) and retinopathy in IDDM and NIDDM patients.
Boemi M, Sirolla C, Amadio L, Fumelli P, James RW. Boemi M, et al. Diabetes Care. 1997 Jan;20(1):115. doi: 10.2337/diacare.20.1.115. Diabetes Care. 1997. PMID: 9028707 No abstract available.
Leukocyte telomere length is associated with complications of type 2 diabetes mellitus.
Testa R, Olivieri F, Sirolla C, Spazzafumo L, Rippo MR, Marra M, Bonfigli AR, Ceriello A, Antonicelli R, Franceschi C, Castellucci C, Testa I, Procopio AD. Testa R, et al. Among authors: sirolla c. Diabet Med. 2011 Nov;28(11):1388-94. doi: 10.1111/j.1464-5491.2011.03370.x. Diabet Med. 2011. PMID: 21692845
+647 A/C and +1245 MT1A polymorphisms in the susceptibility of diabetes mellitus and cardiovascular complications.
Giacconi R, Bonfigli AR, Testa R, Sirolla C, Cipriano C, Marra M, Muti E, Malavolta M, Costarelli L, Piacenza F, Tesei S, Mocchegiani E. Giacconi R, et al. Mol Genet Metab. 2008 May;94(1):98-104. doi: 10.1016/j.ymgme.2007.12.006. Epub 2008 Jan 30. Mol Genet Metab. 2008. PMID: 18249147
C+ carriers was associated with higher glycemia and glycosylated hemoglobin in DCVD patients, but not in DNC or control subjects. ...In summary, this work provides novel evidence on the association of the +647 A/C MT1A polymorphism with DM2. Moreover, C+ carr
C+ carriers was associated with higher glycemia and glycosylated hemoglobin in DCVD patients, but not in DNC or control subjects. ...
C-reactive protein is directly related to plasminogen activator inhibitor type 1 (PAI-1) levels in diabetic subjects with the 4G allele at position -675 of the PAI-1 gene.
Testa R, Bonfigli AR, Sirolla C, Marra M, Boemi M, Mari D, Sacchi E, Dolci A, Catalano A, Procopio A, Ceriello A. Testa R, et al. Nutr Metab Cardiovasc Dis. 2008 Mar;18(3):220-6. doi: 10.1016/j.numecd.2006.10.001. Epub 2007 Apr 12. Nutr Metab Cardiovasc Dis. 2008. PMID: 17433639
BACKGROUND AND AIMS: C-reactive protein (CRP) has been identified as a possible factor able to promote atherosclerosis. "In vitro" studies have demonstrated that CRP induces plasminogen activator inhibitor type 1 (PAI-1) expression, suggesting a hypofibrinolytic role for C …
BACKGROUND AND AIMS: C-reactive protein (CRP) has been identified as a possible factor able to promote atherosclerosis. "In vitro" st …
40 results
Jump to page
Feedback